• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌营养不良症中炎症与纤维化的联系:自分泌运动因子-溶血磷脂酸轴作为新的治疗靶点?

The linkage between inflammation and fibrosis in muscular dystrophies: The axis autotaxin-lysophosphatidic acid as a new therapeutic target?

作者信息

Gallardo Felipe S, Córdova-Casanova Adriana, Brandan Enrique

机构信息

Centro de Envejecimiento y Regeneración, CARE Chile UC, Santiago, Chile.

Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.

出版信息

J Cell Commun Signal. 2021 Sep;15(3):317-334. doi: 10.1007/s12079-021-00610-w. Epub 2021 Mar 10.

DOI:10.1007/s12079-021-00610-w
PMID:33689121
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8222483/
Abstract

Muscular dystrophies (MDs) are a diverse group of severe disorders characterized by increased skeletal muscle feebleness. In many cases, respiratory and cardiac muscles are also compromised. Skeletal muscle inflammation and fibrosis are hallmarks of several skeletal muscle diseases, including MDs. Until now, several keys signaling pathways and factors that regulate inflammation and fibrosis have been identified. However, no curative treatments are available. Therefore, it is necessary to find new therapeutic targets to fight these diseases and improve muscle performance. Lysophosphatidic acid (LPA) is an active glycerophospholipid mainly synthesized by the secreted enzyme autotaxin (ATX), which activates six different G protein-coupled receptors named LPA to LPA (LPARs). In conjunction, they are part of the ATX/LPA/LPARs axis, involved in the inflammatory and fibrotic response in several organs-tissues. This review recapitulates the most relevant aspects of inflammation and fibrosis in MDs. It analyzes experimental evidence of the effects of the ATX/LPA/LPARs axis on inflammatory and fibrotic responses. Finally, we speculate about its potential role as a new therapeutic pharmacological target to treat these diseases.

摘要

肌肉萎缩症(MDs)是一类严重的疾病,其特征是骨骼肌无力加剧。在许多情况下,呼吸肌和心肌也会受到影响。骨骼肌炎症和纤维化是包括肌肉萎缩症在内的几种骨骼肌疾病的标志。到目前为止,已经确定了几个调节炎症和纤维化的关键信号通路和因子。然而,目前尚无治愈性治疗方法。因此,有必要寻找新的治疗靶点来对抗这些疾病并改善肌肉功能。溶血磷脂酸(LPA)是一种活性甘油磷脂,主要由分泌酶自分泌运动因子(ATX)合成,它激活六种不同的G蛋白偶联受体,命名为LPA1至LPA6(LPARs)。它们共同构成了ATX/LPA/LPARs轴,参与多个器官组织的炎症和纤维化反应。本综述概述了肌肉萎缩症中炎症和纤维化的最相关方面。分析了ATX/LPA/LPARs轴对炎症和纤维化反应影响的实验证据。最后,我们推测其作为治疗这些疾病的新治疗药理学靶点的潜在作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5295/8222483/8b8c192d3506/12079_2021_610_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5295/8222483/59fe1ae5d1f6/12079_2021_610_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5295/8222483/adfad46c8472/12079_2021_610_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5295/8222483/7836bb5643ad/12079_2021_610_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5295/8222483/8b8c192d3506/12079_2021_610_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5295/8222483/59fe1ae5d1f6/12079_2021_610_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5295/8222483/adfad46c8472/12079_2021_610_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5295/8222483/7836bb5643ad/12079_2021_610_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5295/8222483/8b8c192d3506/12079_2021_610_Fig4_HTML.jpg

相似文献

1
The linkage between inflammation and fibrosis in muscular dystrophies: The axis autotaxin-lysophosphatidic acid as a new therapeutic target?肌营养不良症中炎症与纤维化的联系:自分泌运动因子-溶血磷脂酸轴作为新的治疗靶点?
J Cell Commun Signal. 2021 Sep;15(3):317-334. doi: 10.1007/s12079-021-00610-w. Epub 2021 Mar 10.
2
Activation of the ATX/LPA/LPARs axis induces a fibrotic response in skeletal muscle.ATX/LPA/LPARs 轴的激活会在骨骼肌中引起纤维化反应。
Matrix Biol. 2022 May;109:121-139. doi: 10.1016/j.matbio.2022.03.008. Epub 2022 Apr 3.
3
The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme.自分泌运动因子-溶血磷脂酸-溶血磷脂酸受体级联反应:一种治疗多形性胶质母细胞瘤新潜在治疗靶点的提议
Lipids Health Dis. 2015 Jun 18;14:56. doi: 10.1186/s12944-015-0059-5.
4
Targeting the autotaxin - Lysophosphatidic acid receptor axis in cardiovascular diseases.靶向自分泌酶-溶血磷脂酸受体轴治疗心血管疾病。
Biochem Pharmacol. 2019 Jun;164:74-81. doi: 10.1016/j.bcp.2019.03.035. Epub 2019 Mar 27.
5
Promising pharmacological directions in the world of lysophosphatidic Acid signaling.具有前景的溶血磷脂酸信号世界中的药理学方向。
Biomol Ther (Seoul). 2015 Jan;23(1):1-11. doi: 10.4062/biomolther.2014.109. Epub 2015 Jan 1.
6
Deregulated Lysophosphatidic Acid Metabolism and Signaling in Liver Cancer.肝癌中溶血磷脂酸代谢与信号传导的失调
Cancers (Basel). 2019 Oct 23;11(11):1626. doi: 10.3390/cancers11111626.
7
Autotaxin and chronic inflammatory diseases.自分泌酶和慢性炎症性疾病。
J Autoimmun. 2019 Nov;104:102327. doi: 10.1016/j.jaut.2019.102327. Epub 2019 Aug 28.
8
Autotaxin in Pathophysiology and Pulmonary Fibrosis.自分泌运动因子在病理生理学和肺纤维化中的作用
Front Med (Lausanne). 2018 Jun 13;5:180. doi: 10.3389/fmed.2018.00180. eCollection 2018.
9
Autotaxin-LPA receptor axis in the pathogenesis of lung diseases.自分泌运动因子-溶血磷脂酸受体轴在肺部疾病发病机制中的作用
Int J Clin Exp Med. 2015 Oct 15;8(10):17117-22. eCollection 2015.
10
Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development.自分泌酶-溶血磷脂酸:从炎症到癌症发展。
Mediators Inflamm. 2017;2017:9173090. doi: 10.1155/2017/9173090. Epub 2017 Dec 21.

引用本文的文献

1
Macrophage-derived Spp1 promotes intramuscular fat in dystrophic muscle.巨噬细胞衍生的Spp1促进营养不良肌肉中的肌内脂肪。
JCI Insight. 2025 Jul 8;10(13). doi: 10.1172/jci.insight.181946.
2
In Old Mice, Exercise Induces Inflammation and Fibrosis Unless Alk5-Inhibitor and Oxytocin Are Used.在老年小鼠中,运动可引发炎症和纤维化,除非使用ALK5抑制剂和催产素。
J Cell Physiol. 2025 Jun;240(6):e70054. doi: 10.1002/jcp.70054.
3
Dysregulated ATX-LPA and YAP/TAZ signaling in dystrophic Sgcd mice with early fibrosis and inflammation.在患有早期纤维化和炎症的营养不良性Sgcd小鼠中,自噬相关蛋白-溶血磷脂酸和Yes相关蛋白/具有PDZ结合基序的转录共激活因子信号失调。

本文引用的文献

1
Interfering with lysophosphatidic acid receptor edg2/lpa signalling slows down disease progression in SOD1-G93A transgenic mice.干扰溶血磷脂酸受体 edg2/lpa 信号可减缓 SOD1-G93A 转基因小鼠的疾病进展。
Neuropathol Appl Neurobiol. 2021 Dec;47(7):1004-1018. doi: 10.1111/nan.12699. Epub 2021 Feb 10.
2
Autotaxin inhibition reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction.自分泌酶抑制减轻心肌梗死后心脏炎症并改善心脏不良重构。
J Mol Cell Cardiol. 2020 Dec;149:95-114. doi: 10.1016/j.yjmcc.2020.09.011. Epub 2020 Oct 2.
3
Structure-Based Discovery of Novel Chemical Classes of Autotaxin Inhibitors.
Skelet Muscle. 2025 Mar 6;15(1):6. doi: 10.1186/s13395-025-00375-5.
4
Autotaxin regulates the expression and the activity of P-glycoprotein in lipopolysaccharide -activated microglial cells.自分泌运动因子调节脂多糖激活的小胶质细胞中P-糖蛋白的表达和活性。
Cytotechnology. 2025 Apr;77(2):58. doi: 10.1007/s10616-025-00727-5. Epub 2025 Feb 12.
5
Macrophages producing chondroitin sulfate proteoglycan-4 induce neuro-cardiac junction impairment in Duchenne muscular dystrophy.产生硫酸软骨素蛋白聚糖-4的巨噬细胞会导致杜氏肌营养不良症患者的神经-心脏连接受损。
J Pathol. 2025 Jan;265(1):1-13. doi: 10.1002/path.6362. Epub 2024 Nov 11.
6
Does β-Hydroxy-β-Methylbutyrate Have Any Potential to Support the Treatment of Duchenne Muscular Dystrophy in Humans and Animals?β-羟基-β-甲基丁酸对支持人类和动物杜氏肌营养不良症的治疗有任何潜力吗?
Biomedicines. 2023 Aug 21;11(8):2329. doi: 10.3390/biomedicines11082329.
7
Duchenne muscular dystrophy: disease mechanism and therapeutic strategies.杜氏肌营养不良症:疾病机制与治疗策略。
Front Physiol. 2023 Jun 26;14:1183101. doi: 10.3389/fphys.2023.1183101. eCollection 2023.
8
Episodic Binge-like Ethanol Reduces Skeletal Muscle Strength Associated with Atrophy, Fibrosis, and Inflammation in Young Rats.间歇性 binge 样乙醇摄入降低年轻大鼠骨骼肌力量与萎缩、纤维化和炎症相关。
Int J Mol Sci. 2023 Jan 14;24(2):1655. doi: 10.3390/ijms24021655.
9
Nano-Immunomodulation: A New Strategy for Skeletal Muscle Diseases and Aging?纳米免疫调节:骨骼肌疾病和衰老的新策略?
Int J Mol Sci. 2023 Jan 7;24(2):1175. doi: 10.3390/ijms24021175.
10
Apolipoprotein D modulates lipid mediators and osteopontin in an anti-inflammatory direction.载脂蛋白 D 向抗炎方向调节脂质介质和骨桥蛋白。
Inflamm Res. 2023 Feb;72(2):263-280. doi: 10.1007/s00011-022-01679-8. Epub 2022 Dec 19.
基于结构的新型 Autotaxin 抑制剂的发现。
Int J Mol Sci. 2020 Sep 23;21(19):7002. doi: 10.3390/ijms21197002.
4
Signalling by lysophosphatidate and its health implications.溶血磷脂酸信号传导及其对健康的影响。
Essays Biochem. 2020 Sep 23;64(3):547-563. doi: 10.1042/EBC20190088.
5
Blocking CTGF/CCN2 reverses neural fibrosis and sensorimotor declines in a rat model of overuse-induced median mononeuropathy.阻断 CTGF/CCN2 逆转了过度使用引起的正中神经单一神经病变大鼠模型中的神经纤维化和感觉运动功能下降。
J Orthop Res. 2020 Nov;38(11):2396-2408. doi: 10.1002/jor.24709. Epub 2020 May 15.
6
MAPK signaling determines lysophosphatidic acid (LPA)-induced inflammation in microglia.丝裂原活化蛋白激酶信号通路决定溶血磷脂酸诱导小胶质细胞炎症反应。
J Neuroinflammation. 2020 Apr 23;17(1):127. doi: 10.1186/s12974-020-01809-1.
7
GPCR-induced YAP activation sensitizes fibroblasts to profibrotic activity of TGFβ1.GPCR 诱导的 YAP 激活使成纤维细胞对 TGFβ1 的促纤维化活性敏感。
PLoS One. 2020 Feb 13;15(2):e0228195. doi: 10.1371/journal.pone.0228195. eCollection 2020.
8
Ectonucleotide pyrophosphatase 2 (ENPP2) plays a crucial role in myogenic differentiation through the regulation by WNT/β-Catenin signaling.核苷酸焦磷酸酶 2(ENPP2)通过 WNT/β-连环蛋白信号通路的调节在成肌分化中发挥关键作用。
Int J Biochem Cell Biol. 2020 Jan;118:105661. doi: 10.1016/j.biocel.2019.105661. Epub 2019 Dec 2.
9
Role of hypoxia in skeletal muscle fibrosis: Synergism between hypoxia and TGF-β signaling upregulates CCN2/CTGF expression specifically in muscle fibers.缺氧在骨骼肌纤维化中的作用:缺氧与 TGF-β 信号的协同作用特异性地上调肌肉纤维中 CCN2/CTGF 的表达。
Matrix Biol. 2020 May;87:48-65. doi: 10.1016/j.matbio.2019.09.003. Epub 2019 Oct 24.
10
Macrophages fine tune satellite cell fate in dystrophic skeletal muscle of mdx mice.巨噬细胞精细调节 mdx 小鼠肌肉营养不良症骨骼肌卫星细胞的命运。
PLoS Genet. 2019 Oct 18;15(10):e1008408. doi: 10.1371/journal.pgen.1008408. eCollection 2019 Oct.